OTCMKTS:MKKGY - MERCK Kommanditgesellschaft auf Aktien Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$31.32
▲ +0.52 (1.69%)
1 month | 3 months | 12 months
Get New MERCK Kommanditgesellschaft auf Aktien Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MKKGY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MKKGY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for MERCK Kommanditgesellschaft auf Aktien in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $31.32.
Hold
The current consensus among 6 contributing investment analysts is to hold stock in MERCK Kommanditgesellschaft auf Aktien. This rating has held steady since April 2020, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/4/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
9/2/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
12/1/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
2/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
5/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/27/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
11/25/2020

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
11/17/2020UBS GroupReiterated RatingNeutral
i
11/16/2020Morgan StanleyReiterated RatingEqual Weight
i
11/13/2020BarclaysReiterated RatingEqual Weight
i
10/30/2020Morgan StanleyReiterated RatingEqual Weight
i
9/17/2020Credit Suisse GroupReiterated RatingOutperform
i
9/15/2020JPMorgan Chase & Co.Reiterated RatingNeutral
i
9/14/2020Morgan StanleyReiterated RatingEqual Weight
i
5/5/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
i
5/5/2020BarclaysReiterated RatingUnderweight
i
5/4/2020Morgan StanleyReiterated RatingEqual Weight
i
6/28/2019Bank of AmericaReiterated RatingNeutral ➝ Underperform
i
4/9/2019Sanford C. BernsteinReiterated RatingOutperform ➝ Mkt Perform
i
3/15/2019UBS GroupReiterated RatingBuy ➝ Neutral
i
10/29/2018Credit Suisse GroupUpgradeNeutral ➝ Outperform
i
5/25/2018DZ BankReiterated RatingNeutral
i
9/26/2017UBS GroupInitiated CoverageBuy ➝ Buy
i
(Data available from 11/25/2015 forward)
MERCK Kommanditgesellschaft auf Aktien logo
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer or multiple sclerosis, infertility, growth hormone deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as carcinoma of the head and neck; prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for the research and applied laboratory applications, as well as for formulating, purifying, manufacturing, and quality-assuring drug therapies of chemical and biological origin; and specialty chemicals, such as liquid crystals and OLED materials for use in displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Intrexon Corporation and Avillion LLP; collaboration with F-star Delta Ltd.; and an agreement IAVI and Serum Institute of India Pvt. Ltd. to develop SARS-CoV-2 neutralizing monoclonal antibodies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
Read More

Today's Range

Now: $31.32
$31.05
$31.32

50 Day Range

MA: $30.70
$29.02
$32.41

52 Week Range

Now: $31.32
$16.55
$32.55

Volume

2,451,148 shs

Average Volume

106,041 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A